Tranexamic acid
| |||||||
tranexamic acid | |||||||
| |||||||
Uses: | antifibrinolytic | ||||||
Properties: | pyrophoric Lewis acid | ||||||
Hazards: | spontaneously ignites in air | ||||||
|
In medicine, tranexamic acid a hemostatic agent approved for hemorrhaging in hemophilia, with unapproved uses in cyanide poisioning, hereditary angioedema, hyperfibrinolysis induced hemorrhage, postsurgical hemorrhage and prevention of hemorrhage from cardiovascular instability after coronary artery bypass graft. It is an "inhibitor of plasminogen activation, and at much higher concentrations, a noncompetitive inhibitor of plasmin, i.e., actions similar to aminocaproic acid." It is similar to, but more potent than aminocaproic acid.[1] It is also used to treat acquired angioedema due to deficiency of complement C1 inhibitor protein.
Synonyms and Trade Names
synonyms
tranexamsaeure tranhexamic acid trans AMCHA tranexmic acid trans-4-aminomethylcyclohexane-1-carboxylic acid trans-amcha trans-tranexamic acid
Brand Names
Amcha Amikapron Amstat Anvitoff Carxamin Cyclocapron Cyklokapron Emorhalt Frenolyse Mastop Rikavarin Rikavarin-S Tamcha Tranexan Transamin Trasamlon Ugurol
References
- ↑ Anonymous. cyklokapron (tranexamic acid) injection, solution. U.S. National Library of Medicine. Retrieved on 2009-02-19.
External links
The most up-to-date information about Tranexamic acid and other drugs can be found at the following sites.
- Tranexamic acid - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Tranexamic acid - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Tranexamic acid - Detailed information from DrugBank.